A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC
Clinical trial NCT05360979 · UNKNOWN
Trial details
- NCT number
- NCT05360979
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-15
- Primary completion
- 2023-05-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.